Hematologic Cancers: From Molecular Pathobiology to Targeted Therapeutics

426 Seiten, Hardcover

Kurzbeschreibung des Verlags

In the last decade, there has been a remarkable explosion of knowledge in hematologic cancer from basic molecular biology and pathology to clinical therapy. This has led to many new advance and insights in the understanding of pathobiology of malignant hematology. New knowledge of disease molecular pathology, cytogenetic, epigenetic and genomic alterations have provided new strategies to attack and eradicate tumor cells at molecular level and significantly impacted our current therapeutics for hematological malignancies. The recent and ongoing rapid expansion of knowledge in this area has become extensive, dynamic and diffuse over the literature and research publications. This has led to the need to capture and compile the new and current information about hematologic cancer with special emphasis on translation from molecular pathobiology to targeted therapeutics. In this book experts from around the world share their thoughts and knowledge about the pathobiology of hematologic cancer,as well as their view on current treatment approaches and future development in these malignant hematologic diseases. This book is well suited for hematology residents, fellows and hematology-oncology physicians, hematopathologist as well as basic research scientist in the area of hematologic malignancies.

• Reihe: Cancer Growth and Progression
• Themen: Medizin Klinische und Innere Medizin Krankheiten und Störungen Onkologie
• ISBN: 9789400750272
• Sprache: Englisch
• Erscheinungsdatum: 13.11.2012
• Größe: 23.5 x 15.5 cm
• Verlag: Springer Netherland
• Herausgegeben von: Jianguo Tao, Eduardo Sotomayor